Ramsey Quantitative Systems bought a new position in shares of Medical Properties Trust, Inc. (NYSE:MPW) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 18,331 shares of the real estate investment trust’s stock, valued at approximately $253,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MPW. First Dallas Securities Inc. bought a new stake in Medical Properties Trust in the fourth quarter valued at approximately $106,000. Ffcm LLC bought a new stake in Medical Properties Trust in the third quarter valued at approximately $116,000. Investors Asset Management of Georgia Inc. GA ADV bought a new stake in Medical Properties Trust in the fourth quarter valued at approximately $138,000. Mcmillion Capital Management Inc. bought a new stake in Medical Properties Trust in the third quarter valued at approximately $137,000. Finally, Janus Henderson Group PLC bought a new stake in Medical Properties Trust in the second quarter valued at approximately $136,000. Institutional investors and hedge funds own 80.07% of the company’s stock.
Shares of Medical Properties Trust, Inc. (NYSE MPW) opened at $12.66 on Friday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 2.55 and a current ratio of 2.06. Medical Properties Trust, Inc. has a 12 month low of $11.82 and a 12 month high of $14.22. The firm has a market capitalization of $4,566.23, a price-to-earnings ratio of 15.44, a price-to-earnings-growth ratio of 2.48 and a beta of 0.79.
Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, February 8th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.02. Medical Properties Trust had a return on equity of 7.85% and a net margin of 41.12%. The firm had revenue of $205.00 million during the quarter, compared to analysts’ expectations of $204.52 million. During the same period in the prior year, the company earned $0.31 earnings per share. The company’s quarterly revenue was up 33.7% on a year-over-year basis. equities analysts anticipate that Medical Properties Trust, Inc. will post 1.44 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 12th. Shareholders of record on Thursday, March 15th will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Wednesday, March 14th. This is a boost from Medical Properties Trust’s previous quarterly dividend of $0.24. This represents a $1.00 annualized dividend and a yield of 7.90%. Medical Properties Trust’s dividend payout ratio is presently 117.07%.
In other Medical Properties Trust news, Chairman Edward K. Aldag, Jr. sold 489,971 shares of the company’s stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $12.39, for a total transaction of $6,070,740.69. Following the completion of the sale, the chairman now directly owns 2,192,629 shares in the company, valued at $27,166,673.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.00% of the stock is owned by corporate insiders.
Several analysts have issued reports on the company. Zacks Investment Research upgraded Medical Properties Trust from a “sell” rating to a “hold” rating in a research note on Tuesday, January 16th. Deutsche Bank lowered Medical Properties Trust from a “buy” rating to a “hold” rating and dropped their price objective for the company from $14.00 to $13.50 in a research note on Wednesday, January 10th. Robert W. Baird lowered Medical Properties Trust from an “outperform” rating to a “neutral” rating and dropped their price objective for the company from $15.00 to $13.00 in a research note on Friday, January 5th. JPMorgan Chase & Co. upgraded Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 price objective on the stock in a research note on Friday, December 15th. Finally, ValuEngine upgraded Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $14.33.
ILLEGAL ACTIVITY NOTICE: This story was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.thelincolnianonline.com/2018/02/24/ramsey-quantitative-systems-invests-253000-in-medical-properties-trust-inc-mpw-stock.html.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.